Chanfta Bhagat Pharma Ltd (BSE: 542934) is a Mumbai, Maharashtra-based company in the Health Care Distributors industry. With a market capitalisation of ₹29 Cr, it ranks #4,302 by market cap among the 6,189 Indian listed companies on FinBizNet, and #5 of 11 in Health Care Distributors. At ₹39.00 (as of 26 Oct 2026), the share price is 26.4% below its 52-week high of ₹52.99 and 31.3% above its 52-week low of ₹29.70. The share price is down 5.1% over one year and up 21.9% over three months.
| Current Price | ₹39.00 |
|---|---|
| Market Cap | ₹29 Cr |
| BSE Code | 542934 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Distributors |
| P/E Ratio | 9.7 |
| Return on Equity | 2.91% |
| Return on Assets | 2.37% |
| 52-Week Range | ₹29.70 – ₹52.99 |
| 1-Year Price Change | -5.1% |
| 3-Month Price Change | +21.9% |
| Beta (1Y) | 0.57 |
| Headquarters | Mumbai, Maharashtra |
| Website | www.cbcpharma.com |
Chandra Bhagat Pharma Limited engages in the marketing of pharmaceutical critical care and health care products in India and internationally. It offers pharmaceutical formulations, including intravenous and intramuscular injections, tablets, and capsules in various therapeutic categories, such as anti-cancer, antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, and neurology to Hospitals and Health care Centers through distribution networks and sales force under its own brand. The company also promotes and markets specialty chemicals, as well as intermediates and active pharmaceuticals ingredients. It also exports its products. The company was founded in 1944 and is headquartered in Mumbai, India.
1. Pharmaceuticals-This segment offers pharmaceutical formulation and active pharmaceuticals ingredient products.
1. Pharmaceutical Formulations and API Products-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Trimurthi Ltd | ₹170 Cr | 49.1 | 7.99% | — | +48.6% |
| Achyut Healthcare Ltd | ₹168 Cr | 535.4 | 0.95% | — | +15.0% |
| Vaidya Sane Ayurved Laboratories | ₹154 Cr | — | 11.99% | — | -43.5% |
| Balaxi Pharmaceuticals Ltd | ₹115 Cr | 81.4 | 0.59% | ₹81 Cr | -50.2% |
| Chanfta Bhagat Pharma Ltd | ₹29 Cr | 9.7 | 2.91% | — | -5.1% |
| Medico Intercontinental Ltd | ₹23 Cr | -7.1 | -27.14% | ₹14 Cr | -34.9% |
| Rubra Medicaments Ltd. | ₹20 Cr | 13.4 | 12.67% | — | -37.7% |
| Zenlabs Ethica Ltd | ₹18 Cr | -9.1 | -20.44% | — | -12.8% |
| Nexus Surgical & Medicare Ltd | ₹14 Cr | 18.6 | 51.41% | — | +76.5% |
Listed by market capitalisation. Ratios are shown for context only.
Chanfta Bhagat Pharma Ltd is trading at ₹39.00, with a market capitalisation of ₹29 Cr.
Chanfta Bhagat Pharma Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Distributors).
Chanfta Bhagat Pharma Ltd has a P/E of 9.7 and a return on equity of 2.91%.
Chanfta Bhagat Pharma Ltd is listed on the BSE under the scrip code 542934.
Chanfta Bhagat Pharma Ltd's share price is down 5.1% over one year and up 21.9% over three months. Its 52-week range is ₹29.70 to ₹52.99.
Data as of 26 Oct 2026. Descriptive market data only — not investment advice.